Impairment of brain vessels may contribute to mortality in patients with Parkinson's disease

Movement Disorders

Volumn 27, Issue 9, 2012, Pages 1169-1172

  Rektor, Ivan ^a,b   Goldemund, David ^b,c   Bednařík, Petr ^a,b   Sheardová, Kateřina ^b,c   Michálková, Zuzana ^b   Telecká, Sabina ^a,b   Dufek, Michal ^b   Rektorová, Irena ^a,b  

^a CENTRAL EUROPEAN INSTITUTE OF TECHNOLOGY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c International Clinical Research Center   (Czech Republic)

Author keywords

Cerebrovascular disease; MRI; Parkinson's disease; Ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN BLOOD VESSEL; COGNITION; ECHOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL; WHITE MATTER;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD VESSELS; BRAIN; CAROTID INTIMA-MEDIA THICKNESS; CLUSTER ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REGRESSION ANALYSIS; SURVIVAL; WECHSLER SCALES;

EID: 84864745126     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25066     Document Type: Article

References (27)

1. Roos RA, Jongen JC, van der Velde EA. Clinical course of patients with idiopathic Parkinson's disease. Mov Disord 1996; 11: 236-242.
2. de Lau LM, Schiller CM, Hofman A, Koudstaal PJ, Breteler MM. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 2005; 62: 1265-1269.
3. Lo RY, Tanner CM, Albers KB, et al. Clinical features in early Parkinson disease and survival. Arch Neurol 2009; 66: 1353-1358.
4. Diem-Zangerl A, Seppi K, Oberaigner W, Poewe W. Mortality in Parkinson's disease: a 20-year follow-up study. Mov Disord 2010; 25: 661-662.
5. Pennington S, Snell K, Lee M, Walker R. The cause of death in idiopathic Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 434-437.
6. Becker C, Jick SS, Meier CR. Risk of stroke in patients with idiopathic Parkinson disease. Parkinsonism Relat Disord 2010; 16: 31-35.
7. Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 2005; 58: 773-776
8. Burton EJ, McKeith IG, Burn DJ, Williams DE, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies, and controls. Brain 2004; 127: 791-800.
9. Santangelo G, Vitale C, Trojano L, De Gaspari D, Bilo L, Antonini A, Barone P. Differential neuropsychological profiles in parkinsonian patients with or without vascular lesions. Mov Disord 2010; 25: 50-56.
10. Papapetropoulos S, Ellul J, Argyriou AA, Talelli P, Chroni E, Papapetropulos T. The effect of vascular disease on late onset Parkinson's disease. Eur J Neurol 2004; 11: 231-235.
11. Haugarvoll K, Aarsland D, Wentzel-Larsen T, Larsen JP. The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease. Acta Neurol Scand 2005; 112: 386-390
12. Slawek J, Wieczorek D, Derejko M, et al. The influence of vascular risk factors and white matter hyperintsities on the degree of cognitive impairment in Parkinson's disease. Neurol Neurochir Pol 2008; 42: 505-512.
13. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
14. Jellinger KA. The neuropathologic diagnosis of secondary parkinsonian syndromes. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S, eds. Advanced Neurology. New York, NY: Raven; 1996; 69: 293-303.
15. Jellinger K, Seppi K, Wenning GK. Neuropathologic changes in Parkinson disease with late onset of dementia. Arch Neurol 2003; 60: 453-454.
16. Rektor I, Goldemund D, Sheardova K, Rektorova I, Michalkova Z, Dufek M. Vascular pathology in patients with idiopathic Parkinson's disease. Parkinsonism Relat Disord 2009; 15: 24-29.
17. Rektor I, Rektorová I, Kubová D. Vascular parkinsonism: an update. J Neurol Sci 2006; 248: 185-191.
18. Jellinger KA. Vascular parkinsonism. Therapy 2008; 5: 237-255.
19. Scheltens P, Barkhof F, Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993; 114( 1): 7-12.
20. Beyer MK, Aarsland D, Greve OJ, Larsen JP. Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord 2006; 21: 223-229.
21. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004; 61: 1531-1534.
22. Papapetropoulos S, Gonzales J, Lieberman A, Villar JM, Mash DC. Dementia in Parkinson's disease: a post-mortem study in a population of brain donors. Int J Geriatr Psychiatry 2005; 20: 418-422.
23. Gorell JM, Johnson CC, Rybicki BA. Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology 1994; 44: 1865-1868.
24. Frauchiger B, Schmid HP, Roedel C, Moosmann P, Staub D. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 2001; 32: 836-841.
25. Lee SJ, Kim JS, Lee KS, et al. The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease. Arch Gerontol Geriatr 2009; 49: 255-259.
26. Korczyn AD. The underdiagnosis of vascular contribution to dementia. J Neurol Sci 2005; 229-230: 3-6.
27. Halliday G, Hely M, Reid W, Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008; 115: 409-415.